Gymnema Sylvestre. I Am Looking for a Gymnema Sylvestre Plant Can Someone Help Me?
Question by Michele O: Gymnema Sylvestre. I am looking for a Gymnema Sylvestre plant can someone help me?
I have recently heard that Gymnema Sylvestre blocks the sugar receptors. i have a terriable “addiction” to sugar and I would like to get rid of it. I would love hear anyones opinion or if they know where I can get a Gymnema Sylvestre plant.
Thank you!!!
Best answer:
Answer by darealqueen
well its a plant thatgrows in Africa and the tropics so you will be unlikely to buy the plant, health food stores sell teas, capsules and liquid extract here is some info on it……………………………………………………………Gymnema sylvestre (GS) is a woody climbing plant that grows in the tropical forests of central and southern India. The leaves are used in herbal medicine preparations. G. sylvestre is known as “periploca of the woods” in English and mesbasringi (meaning “ram’s horn”) in Sanskrit. The leaves, when chewed, interfere with the ability to taste sweetness, which explains the Hindi name gurmar – “destroyer of sugar.”
Plant constituents include two resins (one soluble in alcohol), gymnemic acids, saponins, stigmasterol, quercitol, and the amino acid derivatives betaine, choline and trimethylamine.
Gymnema sylvestre is a stomachic, diuretic, refrigerant, astringent, and tonic. It has been found to increase urine output and reduce hyperglycemia in both animal and human studies.
Gymnema has been used in India for the treatment of diabetes for over 2,000 years. The primary application was for adult-onset diabetes, a condition for which it continues to be recommended today in India. The leaves were also used for stomach ailments, constipation, water retention, and liver disease.
Extracts of G. sylvestre given to patients with type I diabetes on insulin therapy reduces insulin requirements and fasting blood sugar levels, and improves blood sugar control. In a study of type II diabetics, gyrmnema extract given along with oral hypoglycemic drugs was shown to improve blood sugar control and to either lead to discontinuation of the medicine or a significantly reduced dosage. It is interesting to note that gymnema extract given to healthy volunteers does not produce any blood sugar-lowering, or hypoglycemic, effects.
Gymnema sylvestre is one of the Asclepiad strains that grows in South-east Asia. Their therapeutic effects for treating diabetes mellitus, rheumatic arthritis and gout have been well known for a long time. However, the problem is that GS suppresses sweetness and tastes bitter. For this study, we chose Gymnema inodorum (GI) instead of GS, since it has an advantage that it does not suppress sweetness nor is it bitter in taste. Our studies suggest that the component of GI inhibits the increase in the blood glucose level by interfering with the intestinal glucose absorption process.
The effectiveness of GS4, an extract from the leaves of Gymnema sylvestre, in controlling hyperglycemia was investigated in 22 Type 2 diabetic patients on conventional oral anti-hyperglycemic agents. GS4 (400 mg/day) was administered for 18-20 months as a supplement to the conventional oral drugs. During GS4 supplementation, the patients showed a significant reduction in blood glucose, glycosylated haemoglobin and glycosylated plasma proteins, and conventional drug dosage could be decreased. Five of the 22 diabetic patients were able to discontinue their conventional drug and maintain their blood glucose homeostasis with GS4 alone. These data suggest that the beta cells may be regenerated/repaired in Type 2 diabetic patients on GS4 supplementation. This is supported by the appearance of raised insulin levels in the serum of patients after GS4 supplementation.
Answer by nightnurse1960
You’ll need to go to papau new guinea. Instead just buy the supplements at a health food shop, or wall marts. Look on line for nearest outlet to you.
Will legalization spark marijuana research?
Marijuana is listed as a Schedule I drug in the United States as part of the Controlled Substances Act. The classification, which it's held since 1970, defines it as having no medical benefits, no safe use and a high potential for abuse. But that's not …
Read more on The Columbian
High Anxiety
“A number of studies have shown that nearly 20-25 per cent of patients attending primary care settings suffer from depression and anxiety disorders,” says Dr Rakesh Chadda, professor of psychiatry, All India Institute of Medical Sciences (AIIMS), New …
Read more on The New Indian Express
Related Treatment For Alcohol Addiction In India Information…